Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Originator

Robins

3

Pfizer

420

Eli Lilly

237

Merck

216

GlaxoSmithKline

193

All Match

Any Match

Exclude Selected

Exclude Selected

Development Status

US Approved Rx

3

All Match

Any Match

Exclude Selected

Exclude Selected

Primary Target

Potassium channel subfamily K member 3

3

Potassium channel subfamily K member 9

3

All Match

Any Match

Exclude Selected

Exclude Selected

Highest Phase

Approved

3

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

1965

3

All Match

Any Match

Exclude Selected

Exclude Selected

Condition

Chronic pulmonary disease associated with acute hypercapnia

3

Drug-induced postanesthesia respiratory depression

3

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Primary

3

Secondary

3

All Match

Any Match

Exclude Selected

Exclude Selected

CNS Activity

CNS Active

3

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

3

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

CAS

3

EPA CompTox

3

FDA UNII

3

PUBCHEM

3

SMS_ID

3

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 1

RESPIRATORY SYSTEM

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 2

OTHER RESPIRATORY SYSTEM PRODUCTS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 3

OTHER RESPIRATORY SYSTEM PRODUCTS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 4

Respiratory stimulants

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Salts, Hydrates, Esters, etc.

2

Principal Form

1

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 1 - 3 of 3 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

DOXAPRAM

94F3830Q73

Export Data
Search for Structure

Status:

US Approved Rx (2003)

First approved in 1965

Class (Stereo):

CHEMICAL (RACEMIC)

Targets:

Potassium channel subfamily K member 3

Potassium channel subfamily K member 9

Conditions:

Drug-induced postanesthesia respiratory depression

Chronic pulmonary disease associated with acute hypercapnia

Doxapram is an analeptic agent (a stimulant of the central nervous system). The respiratory stimulant action is manifested by an increase in tidal volume associated with a slight increase in respiratory rate. A pressor response may result following d...

oxapram administration. Provided there is no impairment of cardiac function, the pressor effect is more marked in hypovolemic than in normovolemic states. The pressor response is due to the improved cardiac output rather than peripheral vasoconstriction. Following doxapram administration, an increased release of catecholamines has been noted. Doxapram produces respiratory stimulation mediated through the peripheral carotid chemoreceptors. It is thought to stimulate the carotid body by inhibiting certain potassium channels. Used as temporary measure in hospitalized patients with acute respiratory insufficiency superimposed on chronic obstructive pulmonary disease.

DOXAPRAM HYDROCHLORIDE

P5RU6UOQ5Y

Export Data
Search for Structure

Status:

US Approved Rx (2003)

First approved in 1965

Class (Stereo):

CHEMICAL (RACEMIC)

Targets:

Potassium channel subfamily K member 3

Potassium channel subfamily K member 9

Conditions:

Drug-induced postanesthesia respiratory depression

Chronic pulmonary disease associated with acute hypercapnia

Doxapram is an analeptic agent (a stimulant of the central nervous system). The respiratory stimulant action is manifested by an increase in tidal volume associated with a slight increase in respiratory rate. A pressor response may result following d...

oxapram administration. Provided there is no impairment of cardiac function, the pressor effect is more marked in hypovolemic than in normovolemic states. The pressor response is due to the improved cardiac output rather than peripheral vasoconstriction. Following doxapram administration, an increased release of catecholamines has been noted. Doxapram produces respiratory stimulation mediated through the peripheral carotid chemoreceptors. It is thought to stimulate the carotid body by inhibiting certain potassium channels. Used as temporary measure in hospitalized patients with acute respiratory insufficiency superimposed on chronic obstructive pulmonary disease.

DOXAPRAM HYDROCHLORIDE ANHYDROUS

FB8713U6DM

Export Data
Search for Structure

Status:

US Approved Rx (2003)

First approved in 1965

Class (Stereo):

CHEMICAL (RACEMIC)

Targets:

Potassium channel subfamily K member 3

Potassium channel subfamily K member 9

Conditions:

Drug-induced postanesthesia respiratory depression

Chronic pulmonary disease associated with acute hypercapnia

Doxapram is an analeptic agent (a stimulant of the central nervous system). The respiratory stimulant action is manifested by an increase in tidal volume associated with a slight increase in respiratory rate. A pressor response may result following d...

oxapram administration. Provided there is no impairment of cardiac function, the pressor effect is more marked in hypovolemic than in normovolemic states. The pressor response is due to the improved cardiac output rather than peripheral vasoconstriction. Following doxapram administration, an increased release of catecholamines has been noted. Doxapram produces respiratory stimulation mediated through the peripheral carotid chemoreceptors. It is thought to stimulate the carotid body by inhibiting certain potassium channels. Used as temporary measure in hospitalized patients with acute respiratory insufficiency superimposed on chronic obstructive pulmonary disease.

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1